Too little, too late: Ineffective regulation of dietary supplements in the United States

American Journal of Public Health

Volumn 105, Issue 3, 2015, Pages 478-485

  Starr, Ranjani R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; ADVERTIZING; DIET SUPPLEMENTATION; FOOD AND DRUG ADMINISTRATION; HUMAN; LEGISLATION AND JURISPRUDENCE; MARKETING; PRACTICE GUIDELINE; PRODUCT SAFETY; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADVERTISING AS TOPIC; CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; GUIDELINES AS TOPIC; HUMANS; MARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84922724408     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302348     Document Type: Article

References (82)

1. Dietary Supplement Health and Education Act of 1994, Pub L 103-417, 108 Stat. 4325.
2. US Government Accountability Office. Dietary Supplements: FDA Should Take Further Actions to Improve Oversight and Consumer Understanding. Washington, DC: US Government Accountability Office; 2009. GAO-09-GAO-250.
3. Natural Medicines Comprehensive Database. About Natural Medicines Comprehensive Database. Available at: http://naturaldatabase.therapeuticresearch. com/Content.aspx?cs=&s=ND&page= aboutdbhtml&xsl=generic. Accessed August 15, 2014.
4. US Government Accountability Office. Dietary Supplements-FDA May Have Opportunities to Expand Its Use of Reported Health Problems to Oversee Products. Washington, DC: US Government Accountability Office; 2013:13-244.
5. Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United States, 2003-2006. J Nutr. 2011;141(2):261-266.
6. Wu CH, Wang CC, Kennedy J. Changes in herb and dietary supplement use in the US adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther. 2011;33(11):1749-1758.
7. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355-361.
8. Marinac JS, Buchinger CL, Godfrey LA, Wooten JM, Sun C, Willsie SK. Herbal products and dietary supplements: a survey of use, attitudes and knowledge among older adults. J Am Osteopath Assoc. 2007;107(1):13-20.
9. Office of Inspector General. Adverse Event Reporting for Dietary Supplements: An Inadequate Safety Valve. Washington, DC: US Department of Health and Human Services, Office of Inspector General; 2001. OEI-01-00-00180.
10. Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the US Preventive Services Task Force. Ann Intern Med. 2013;159(12):824-834.
11. Guallar E, Stranges S, Mulrow C, Appel LJ, Miller ER 3rd. Enough is enough: stop wasting money on vitamin and mineral supplements. Ann Intern Med. 2013;159(12):850-851.
12. Huang HY, Caballero B, Chang S, et al. The efficacy and safety of multivi-tamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med. 2006; 145(5):372-385.
13. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142 (1):37-46.
14. Bjelakovic G, Nikolova D, Gluud C. Antioxidant supplements to prevent mortality. JAMA. 2013;310(11):1178-1179.
15. US Government Accountability Office. Herbal Dietary Supplements: Examples of Deceptive or Questionable Marketing Practices and Potentially Dangerous Advice. Washington, DC: US Government Accountability Office; 2010:10-662T.
16. Glisson JK, Rogers HE, Abourashed EA, Ogletree R, Hufford CD, Khan I. Clinic at the health food store? Employee recommendations and product analysis. Pharmacotherapy. 2003;23(1):64-72.
17. Gotay CC, Dumitriu D. Health food store recommendations for breast cancer patients. Arch Fam Med. 2000;9(8): 692-699.
18. Buckner KD, Chavez ML, Raney EC, Stoehr JD. Health food stores' recommendations for nausea and migraines during pregnancy. Ann Pharmacother. 2005;39(2):274-279.
19. Temple NJ, Eley D, Nowrouzi B. Advice on dietary supplements: a comparison of health food stores and pharmacies in Canada. J Am Coll Nutr. 2009;28(6):674-677.
20. Tsai HH, Lin HW, Simon Pickard A, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. Int J Clin Pract. 2012; 66(11):1056-1078.
21. Dasgupta A. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am J Clin Pathol. 2003;120:127-137.
22. Barnes J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: efficacy and safety. Br J Clin Pharmacol. 2003;55(4): 331-340.
23. Grubbs V, Plantinga LC, Tuot DS, et al. Americans' use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis. 2013;61(5):739-747.
24. Gabardi S, Munz K, Ulbricht C. A review of dietary supplement-induced renal dysfunction. Clin J Am Soc Nephrol. 2007;2(4):757-765.
25. Cohen PA. American roulette-contaminated dietary supplements. N Engl J Med. 2009;361(16):1523-1525.
26. Kassel MA. From a history of near misses: the future of dietary supplement regulation. Food Drug Law J. 1994;49: 237-270.
27. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008;168(4):404-410.
28. Amrein K, Quraishi S, Litonjua A, et al. Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab. 2014;99(4):1461-1469.
29. Goyal A, Terry M, Siegel A. Serum antioxidant nutrients, vitamin A, and mortality in US adults. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2202-2211.
30. Palmer ME, Haller C, McKinney PE, et al. Adverse events associated with dietary supplements: an observational study. Lancet. 2003;361(9352):101-106.
31. Nowak RE. DSHEA's failure: why a proactive approach to dietary supplement regulation is needed to effectively protect consumers. Univ Ill Law Rev. 2010;2010:1045-1068.
32. Kaczka KA. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products. J Contemp Health Law Policy. 2000;16(2):463-499.
33. Pinco RG, Rubin PD. Ambiguities of the Dietary Supplement Health and Education Act of 1994. Food Drug Law J. 1996;51(3):383-405.
34. Onel S. Dietary supplements: a definition that is black, white and gray. Am J Law Med. 2005;31(2-3):341-348.
35. Hutt PB. FDA statutory authority to regulate the safety of dietary supplements. Am J Law Med. 2005;31(2-3): 155-174.
36. Quinones RL, Winsor RD, Patino A, Hoffman P. The regulation of dietary supplements within the United States: flawed attempts at mending a defective consumer safety mechanism. J Consum Aff. 2013;47(2):328-357.
37. Kauflin S. Dietary supplements: is availability worth the risks? Proposed alternatives to the present DSHEA scheme. Seton Hall Law Rev. 2003; 33(2):411-446.
38. Fontanarosa PB, Rennie D, DeAngelis CD. The need for regulation of dietary supplements-lessons from ephedra. JAMA. 2003;289(12):1568-1570.
39. Cohen PA. Assessing supplement safety-the FDA's controversial proposal. N Engl J Med. 2012;366(5):389-391.
40. US Food and Drug Administration. Nutrition labeling. In: Dietary Supplement Labeling Guide. Available at: http://www. fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/DietarySupplements/ucm070597.htm. Accessed June 15, 2014.
41. Soltis CA. Between a rock and a hard place: FDA's regulation of dietary ingredients in dietary supplements. J Food Law Policy. 2006;2(11):11-38.
42. US Food and Drug Administration. Recalls, market withdrawals, & safety alerts. Available at: http://www.fda.gov/Safety/recalls/default.htm. Accessed December 10, 2013.
43. US Food and Drug Administration. Draft guidance for industry: dietary supplements. Available at: http://www. fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/dietarysupplements/ucm257563.htm. Accessed June 15, 2014.
44. US Food and Drug Administration. Good manufacturing practice (GMP) guidelines/inspection checklist. Available at: http://www.fda.gov/Cosmetics/GuidanceRegulation/GuidanceDocuments/ucm2005190.htm. Accessed December 1, 2013.
45. Sachs M. Ephedra and the failure of dietary supplement regulation. Cathol Univers Law Rev. 2005;54: 661-702.
46. Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222-235.
47. Long J. FDA data: supplement cGMP compliance rates show modest improvement. Available at: http://www. naturalproductsinsider.com/news/2014/02/fda-data-supplement-cgmp-compliance-rates-show-mo.aspx. Accessed June 15, 2014.
48. Miller RK, Celestino C, Giancaspro GI, Williams RL. FDA's dietary supplement cGMPs: standards without standardization. Food Drug Law J. 2008; 63(4):929-942.
49. US Pharmacopeial Convention. USP verified dietary supplements. Available at: http://www.usp.org/usp-verification-services/usp-verified-dietary-supplements/verified-supplements. Accessed May 28, 2014.
50. LeBlanc ES, Perrin N, Johnson JD Jr, Ballatore A, Hillier T. Over-the-counter and compounded vitamin D: is potency what we expect? JAMA Intern Med. 2013;173(7): 585-586.
51. Dietary Supplement and Nonpre-scription Drug Consumer Protection Act, Pub L 109-462, 120 Stat. 4500.
52. Crawford SY, Leventis C. Herbal product claims: boundaries of marketing and science. J Consumer Marketing. 2005;22(7):432-441.
53. Denham BE. Dietary supplements-regulatory issues and implications for public health. JAMA. 2011;306(4):428-429.
54. Office of Inspector General. Dietary Supplement Labels: An Assessment. Washington, DC: US Department of Health and Human Services, Office of Inspector General; 2003. OEI-01-01-00121.
55. Mason MJ, Scammon DL, Fang X. The impact of warnings, disclaimers, and product experience on consumers' perceptions of dietary supplements. J Consum Aff. 2007;41 (1):74-99.
56. DeLorme DE, Huh J, Reid LN, An S. Dietary supplement advertising in the US: a review and research agenda. Int J Advert. 2012;31(3):547-577.
57. Villafranco JE, Bond K. Dietary supplement labeling and advertising claims: are clinical studies on the full product required? Food Drug Law J. 2009;64(1):43-67.
58. Hastak M, Mazis M. Effect of Consumer Testimonials in Weight Loss, Dietary Supplement and Business Opportunity Advertisements. Washington, DC: Federal Trade Commission; 2004.
59. Federal Trade Commission, Bureau of Consumer Protection Business Center. Dietary supplements: An advertising guide for industry. Available at: http://www.business.ftc.gov/documents/bus09-dietary-supplements-advertising-guide-industry. Accessed June 15, 2014.
60. Villafranco JE, Lustigman AB. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division. Food Drug Law J. 2007;62(4): 709-725.
61. Nguyen ES. Potential FTC restrictions on diet advertising. Food Drug Law J. 2008;63(2):493-507.
62. Zigler J. A free market for dietary supplements: issues surrounding DSHEA's exceptions to the labeling exemption for third-party literature. Food Drug Law J. 2007;62(1): 151-163.
63. Morris CA, Avorn J. Internet marketing of herbal products. JAMA. 2003;290(11):1505-1509.
64. Chung EP, Hwang HJ, Kim MK. Evaluation of non-English dietary supplement advertisements in an ethnic minority community in America. Public Health Nutr. 2007;10(8): 834-837.
65. Office of Inspector General. Dietary Supplements: Companies May Be Difficult to Locate in an Emergency. Washington, DC: US Department of Health and Human Services, Office of Inspector General; 2012. OEI-01-11-00211.
66. Harel Z, Harel S, Wald R, Madani M, Bell CM. The frequency and characteristics of dietary supplement recalls in the United States. JAMA Intern Med. 2013; 173(10):926-928.
67. Ashar BH, Rowland-Seymour A. Advising patients who use dietary supplements. Am J Med. 2008;121(2): 91-97.
68. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans' views on the use and regulation of dietary supplements. Arch Intern Med. 2001; 161 (6):805-810.
69. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int. 2000;15(3): 259-267.
70. Dodge T, Litt D, Kaufman A. Influence of the Dietary Supplement Health and Education Act on consumer beliefs about the safety and effectiveness of dietary supplements. J Health Commun. 2011;16(3):230-244.
71. Legum JC. The dangers of DSHEA: a case for expanded FDA authority over dietary supplements. J Med Law. 2002; 6:103-122.
72. Harris IM. Regulatory and ethical issues with dietary supplements. Pharmacotherapy. 2000; 20(11):1295-1302.
73. Farina EK, Austin K, Liberman H. Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions. J Acad Nutr Diet; 2014;114(11):1784-1790.e2.
74. Peng CC, Glassman PA, Trilli LE, Hayes-Hunter J, Good CB. Incidence and severity of potential drug-dietary supplement interactions in primary care patients. Arch Intern Med. 2004;164(6): 630-636.
75. Terrie Y. Drug-supplement interactions: patient awareness is key. Available at: http://www.pharmacytimes.com/publications/issue/2013/October2013/Drug-Supplement-Interactions-Patient-Awareness-Is-Key. Accessed June 10, 2014.
76. Azizi R. "Supplementing" the DSHEA: Congress must invest the FDA with greater regulatory authority over nutraceutical manufacturers by amending the Dietary Supplement Health and Education Act Calif Law Rev. 2010;98:439-480.
77. Ng S, Rockoff J. With top lines drooping, firms reach for vitamins. Wall Street Journal. March 31, 2013. Available at: http://online.wsj.com/news/articles/SB10001424127887324392804578362073624344816. Accessed June 5, 2014.
78. Associated Press. Many vitamins, supplements made by big pharmaceutical companies. Available at: http://www.foxnews.com/story/2009/06/10/manyvitamins-supplements-made-by-bigpharmaceutical-companies. Accessed September 14, 2014.
79. Burns LR, Lawrence DM, Sammut SM. Healthcare innovation across sectors: convergences and divergences. In: Burns LR, ed. The Business of Healthcare Innovation. 2nd ed. New York, NY: Cambridge University Press; 2012: 515-563.
80. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22(2):151-185.
81. Moyer VA; US Preventive Services Task Force. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160(8):558-564.
82. Moyer VA; US Preventive Services Task Force. Vitamin D and calcium supplementation to prevent fractures in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;158(9): 691-696.